Evidence map›Paper›PMID 33103257›Full record

ReviewMedicinal research reviews2021

Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases.

Alexander G Panossian, Thomas Efferth, Alexander N Shikov, Olga N Pozharitskaya, Kenny Kuchta, Pulok K Mukherjee, Subhadip Banerjee, Michael Heinrich, Wanying Wu, De-An Guo and 1 more

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Medicinal research reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04795557 (Effect of ADAPT232 Supplementation on Recovery of Patients in Rehabilitation Period in Long COVID-19), which is not on this map. Cited by 106 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 4 pooled it
15.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04795557 phase2 / phase3completednot on this map

Effect of ADAPT232 Supplementation on Recovery of Patients in Rehabilitation Period in Long COVID-19: a Randomized, Double-blind, Placebo-controlled Trial

TypeinterventionalSponsorSwedish Herbal Institute ABRan2021 to 2021Enrolled100ConditionsCovid19ArmsADAPT-232 oral solution, Placebo oral solution
3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 4 syntheses or guidelines pooled it, 320 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Efficacy and safety of three species ofFrontiers in pharmacology · 2023
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Exploring the efficacy and safety of a novel standardized ashwagandha (Journal of psychopharmacology (Oxford, England) · 2023
    Trial
  9. Article
  10. Article
  11. Review
  12. Antioxidants (Basel, Switzerland) · 2026
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 6 countries.

Alexander G PanossianPhytomed AB, Vaxtorp, Sweden.ORCID 0000-0002-8467-4525
Thomas EfferthDepartment of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Germany.ORCID 0000-0002-2637-1681
Alexander N ShikovDepartment of technology of dosage forms, Saint-Petersburg State Chemical-Pharmaceutical University, St. Petersburg, Russia.
Olga N PozharitskayaDepartment of Biotechnology, Murmansk Marine Biological Institute of the Kola Science Center of the Russian Academy of Sciences (MMBI KSC RAS), Murmansk, Russia.
Kenny KuchtaDepartment of Far Eastern Medicine, Clinic for Gastroenterology and Gastrointestinal Oncology, University Medical Center Göttingen, Göttingen, Germany.
Pulok K MukherjeeDepartment of Pharmaceutical Technology, School of Natural Product Studies, Jadavpur University, Kolkata, India.
Subhadip BanerjeeDepartment of Pharmaceutical Technology, School of Natural Product Studies, Jadavpur University, Kolkata, India.
Michael HeinrichResearch Cluster Biodiversity and Medicines, UCL School of Pharmacy, Centre for Pharmacognosy and Phytotherapy, University of London, London, UK.
Wanying WuShanghai Research Center for TCM Modernization, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
De-An GuoShanghai Research Center for TCM Modernization, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Hildebert WagnerDepartment of Pharmacy, Center for Pharma Research, Ludwig-Maximilians-Universität München, Munich, Germany.
Chinese Academy of Sciences · CNJadavpur University · INJohannes Gutenberg University Mainz · DELudwig-Maximilians-Universität München · DEMurmansk Marine Biological Institute · RUSaint - Petersburg State Chemical Pharmaceutical Academy · RUUniversitätsmedizin Göttingen · DEUniversity of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adaptogens comprise a category of herbal medicinal and nutritional products promoting adaptability, resilience, and survival of living organisms in stress. The aim of this review was to summarize the growing knowledge about common adaptogenic plants used in various traditional medical systems (TMS) and conventional medicine and to provide a modern rationale for their use in the treatment of stress-induced and aging-related disorders. Adaptogens have pharmacologically pleiotropic effects on the neuroendocrine-immune system, which explain their traditional use for the treatment of a wide range of conditions. They exhibit a biphasic dose-effect response: at low doses they function as mild stress-mimetics, which activate the adaptive stress-response signaling pathways to cope with severe stress. That is in line with their traditional use for preventing premature aging and to maintain good health and vitality. However, the potential of adaptogens remains poorly explored. Treatment of stress and aging-related diseases require novel approaches. Some combinations of adaptogenic plants provide unique effects due to their synergistic interactions in organisms not obtainable by any ingredient independently. Further progress in this field needs to focus on discovering new combinations of adaptogens based on traditional medical concepts. Robust and rigorous approaches including network pharmacology and systems pharmacology could help in analyzing potential synergistic effects and, more broadly, future uses of adaptogens. In conclusion, the evolution of the adaptogenic concept has led back to basics of TMS and a new level of understanding of holistic approach. It provides a rationale for their use in stress-induced and aging-related diseases.

Indexed as

Plant ExtractsSignal TransductionAgingHumansPlant Extractsadaptogenagingethnopharmacologynetwork pharmacologystress

Identifiers

PMID33103257
PMCPMC7756641
OpenAlexW3093753665

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.